Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

New oral treatment, finasteride, effectively and safely treats common hair loss.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Combining low-level light therapy with minoxidil helps hair regrowth better than using minoxidil alone, especially early on.

Combining Low Level Light Therapy and minoxidil may help with hair growth, but more research is needed.

5% minoxidil is safe and effective for treating male hair loss.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

Baricitinib works better than methotrexate for severe alopecia areata.

Topical minoxidil, intralesional steroids, and cryotherapy significantly improve alopecia areata.

Scalp clarifying shampoo can help reduce hair loss and improve hair volume.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Bimatoprost effectively and safely improves eyebrow appearance.

The 810-nm diode laser improves skin texture in keratosis pilaris but not redness.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

More inclusive research is needed to effectively treat frontal fibrosing alopecia in Black patients.

Baricitinib is an effective treatment for severe alopecia areata.

Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Topical minoxidil may slow hair loss but often doesn't lead to satisfactory hair regrowth and requires ongoing treatment.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Temozolomide improves survival in grade III glioma patients without harming quality of life.